BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33334068)

  • 1. Intrinsic Angiogenic Potential and Migration Capacity of Human Mesenchymal Stromal Cells Derived from Menstrual Blood and Bone Marrow.
    Santos RA; Asensi KD; de Barros JHO; de Menezes RCS; Cordeiro IR; Neto JMB; Kasai-Brunswick TH; Goldenberg RCDS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product.
    Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
    Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
    Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study.
    Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G
    Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minicircle-based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues.
    Serra J; Alves CPA; Cabral JMS; Monteiro GA; da Silva CL; Prazeres DMF
    J Gene Med; 2021 Jul; 23(7):e3342. PubMed ID: 33870576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.
    Alcayaga-Miranda F; Cuenca J; Luz-Crawford P; Aguila-Díaz C; Fernandez A; Figueroa FE; Khoury M
    Stem Cell Res Ther; 2015 Mar; 6(1):32. PubMed ID: 25889741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy.
    Serra J; Alves CPA; Brito L; Monteiro GA; Cabral JMS; Prazeres DMF; da Silva CL
    Hum Gene Ther; 2019 Mar; 30(3):316-329. PubMed ID: 30200778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
    Du WJ; Chi Y; Yang ZX; Li ZJ; Cui JJ; Song BQ; Li X; Yang SG; Han ZB; Han ZC
    Stem Cell Res Ther; 2016 Nov; 7(1):163. PubMed ID: 27832825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells.
    Kang IS; Suh J; Lee MN; Lee C; Jin J; Lee C; Yang YI; Jang Y; Oh GT
    BMB Rep; 2020 Feb; 53(2):118-123. PubMed ID: 31964470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.
    Chadid T; Morris A; Surowiec A; Robinson S; Sasaki M; Galipeau J; Pollack BP; Brewster LP
    J Vasc Surg; 2018 Dec; 68(6S):137S-151S.e2. PubMed ID: 30104096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
    Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
    J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured cell-derived extracellular matrices to enhance the osteogenic differentiation and angiogenic properties of human mesenchymal stem/stromal cells.
    Carvalho MS; Silva JC; Cabral JMS; da Silva CL; Vashishth D
    J Tissue Eng Regen Med; 2019 Sep; 13(9):1544-1558. PubMed ID: 31151132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the in vitro angiogenic potential of human mesenchymal stromal cells from different tissue sources.
    Pinto DS; Ahsan T; Serra J; Fernandes-Platzgummer A; Cabral JMS; da Silva CL
    J Cell Physiol; 2020 Oct; 235(10):7224-7238. PubMed ID: 32037550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of extracellularly supplemented osteopontin and osteocalcin on stem cell proliferation, osteogenic differentiation, and angiogenic properties.
    Carvalho MS; Cabral JM; da Silva CL; Vashishth D
    J Cell Biochem; 2019 Apr; 120(4):6555-6569. PubMed ID: 30362184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells.
    Dao M; Tate CC; McGrogan M; Case CC
    J Transl Med; 2013 Mar; 11():81. PubMed ID: 23531336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
    Ding W; Knox TR; Tschumper RC; Wu W; Schwager SM; Boysen JC; Jelinek DF; Kay NE
    Blood; 2010 Oct; 116(16):2984-93. PubMed ID: 20606160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor.
    Carrion B; Kong YP; Kaigler D; Putnam AJ
    Exp Cell Res; 2013 Nov; 319(19):2964-76. PubMed ID: 24056178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the potential of the secretome of mesenchymal stem cells derived from sickle cell disease patients.
    Ribeiro TO; Silveira BM; Meira MC; Carreira ACO; Sogayar MC; Meyer R; Fortuna V
    PLoS One; 2019; 14(10):e0222093. PubMed ID: 31665139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
    Fan W; Crawford R; Xiao Y
    Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting therapeutic angiogenesis of focal cerebral ischemia using thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) in a rat model.
    Zhang Q; Zhou M; Wu X; Li Z; Liu B; Gao W; Yue J; Liu T
    J Transl Med; 2019 Apr; 17(1):111. PubMed ID: 30947736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.